Barclays »

Halozyme Therapeutics shares owned by Barclays

Quarter-by-quarter ownership of Halozyme Therapeutics (HALO) shares owned by Barclays from 13F filings

Historical chart of Barclays investment in Halozyme Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Halozyme Therapeutics held by Barclays consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Halozyme Therapeutics by Barclays

Quarter filed Position value Share count Share price at filing
2013-03-31 $2.2M 388k 5.76
2012-12-31 $1.5M 231k 6.71
2012-09-30 $3.4M 458k 7.54
2012-03-31 $5.8M 458k 12.76
2011-12-31 $1.6M 172k 9.51
2011-09-30 $105k 17k 6.15
2011-06-30 $490k 71k 6.91
2011-03-31 $102k 15k 6.64
2010-12-31 $138k 18k 7.90